Antonio Frassoldati

11PUBLICATIONS
83CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersNutrigenomics and personalised nutritionLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Feb 05, 2024
Single-Agent Trabectedin Versus Physician's Choice Chemotherapy in Patients With Recurrent Ovarian Cancer With BRCA-Mutated and/or BRCAness Phenotype: A Randomized Phase III Trial.

Domenica Lorusso, Francesco Raspagliesi, Dominique Ronzulli

|Oct 27, 2023
SNP of Aromatase Predict Long-term Survival and Aromatase Inhibitor Toxicity in Patients with Early Breast Cancer: A Biomarker Analysis of the GIM4 and GIM5 Trials.

Benedetta Conte, Luca Boni, Giancarlo Bisagni

|Sep 07, 2023
Metastatic site patterns by intrinsic subtype and HER2DX in early HER2-positive breast cancer.

Maria Vittoria Dieci, PierFranco Conte, Giancarlo Bisagni

|Jun 28, 2023
The Impact of NUTRItional Status at First Medical Oncology Visit on Clinical Outcomes: The NUTRIONCO Study.

Maurizio Muscaritoli, Alessandra Modena, Matteo Valerio

|Apr 12, 2023
Author Correction: Type of adjuvant endocrine therapy and disease-free survival in patients with early HR-positive/HER2-positive BC: analysis from the phase III randomized ShortHER trial.

Maria Vittoria Dieci, Giancarlo Bisagni, Stefania Bartolini

|Feb 04, 2023
Type of adjuvant endocrine therapy and disease-free survival in patients with early HR-positive/HER2-positive BC: analysis from the phase III randomized ShortHER trial.

Maria Vittoria Dieci, Giancarlo Bisagni, Stefania Bartolini

Pageof 2

Frequent Collaborators

3 joint publications

Sara Balduzzi

3 joint publications

Maria Vittoria Dieci

3 joint publications

Valentina Guarneri

3 joint publications

Roberto Vicini